Search

everythinglearnresearchcommunity

for

Search:↓

Scalp cooling effectively prevents severe hair loss in breast cancer patients treated with docetaxel and is safe.

Japan improved its regulation of regenerative medicine to ensure safety and prevent unproven treatments.

The study created a test that found hormonal and toxic effects in plant and fungal extracts using prostate cancer cells.

Certain plant extracts can effectively treat skin conditions like athlete's foot, chronic vein problems, sun damage, skin growths, vitiligo, and hair loss, and may also improve skin appearance.

Curcumin and its derivatives can block an enzyme important for making testosterone, with one derivative being particularly strong.

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

HPV genes in mice improve ear tissue healing by speeding up skin growth and repair.

Mechlorethamine treatment regrew hair in mice by killing immune cells causing hair loss without harming hair follicles.

As of 1994, treatments for liver cancer had not significantly improved patient survival.

Spironolactone, a heart and liver drug, has new uses including cancer treatment, viral infection prevention, and skin condition improvement.

DA-9401 helps protect rat testis from finasteride damage.

EGFR inhibitors can cause various skin issues during cancer treatment, and managing these is important for patient care.

Patients with myotonic dystrophy often have skin problems that suggest early aging and vitamin D issues, and the severity of these problems is linked to their genetic condition and vitamin D levels.

The study concludes that certain domains in Clostridium histolyticum enzymes are structurally unique, bind calcium to become more stable, and play distinct roles in breaking down collagen, with potential applications in medicine and drug delivery.

Familial factors affect hair loss types in Koreans, with M type in men, L type in women, and paternal factors influencing male hair loss more.

Dihydrotestosterone causes p27 protein breakdown in ovarian and breast cancer cells by binding with SKP2.

Treating hirsutism in women often requires a mix of medications and cosmetic methods for best results.

Melatonin-loaded nanocarriers improve melatonin delivery and effectiveness for various medical treatments.

Compounds from the plant Mammea siamensis may help treat hair loss.

Low testosterone in men is a risk factor for a specific heart rhythm issue, and testosterone treatment may help prevent it.

The formula YH0618 can reduce the harmful side effects of the chemotherapy drug Doxorubicin and protect healthy cells.

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.

Old treatments for other skin conditions showed promise for hair regrowth in mice with a hair loss condition.

New markers and pathways have been found in skin tumors, helping better understand and diagnose them.

The article suggests that targeting specific immune pathways could help control and treat the skin disease hidradenitis suppurativa.

Minoxidil can stop the growth of ovarian cancer cells without harming the heart.

The PS-b-PAA copolymer nanomicelles are effective for delivering a cancer treatment drug in photodynamic therapy.

Certain genetic markers linked to reproductive potential were identified by their impact on a protein's ability to bind to genes.

Platelet-rich plasma may help hair follicle cells grow by affecting certain genes and pathways.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.